Posts With Tag NASDAQ LVTX

Showing 1 - 2 of 2 Posts

LAVA Therapeutics NV 8-K Report: Key Financial Insights as of February 20, 2025

•

Form 8-K

•

2025-02-25

Last updated: 3 months ago

LAVA Therapeutics NV 8-K Report: Key Financial Insights as of February 20, 2025

Explore LAVA Therapeutics NV's latest 8-K filing detailing common shares, nominal value, and compliance under SEC regulations. Stay informed on LVTX's financial performance.

LAVA Therapeutics biotechnology NASDAQ LVTX financial reporting SEC compliance

LAVA Therapeutics NV 8-K Report: Key Insights on Corporate Developments

•

Form 8-K

•

2025-01-02

Last updated: 6 months ago

LAVA Therapeutics NV 8-K Report: Key Insights on Corporate Developments

Explore LAVA Therapeutics NV's SEC 8-K report dated January 1, 2025, highlighting significant corporate events and shareholder impacts.

LAVA Therapeutics biotechnology NASDAQ LVTX SEC 8-K filing corporate announcements